While diabetes gets a lot of attention, people with Type 1 Diabetes (T1D) are frequently overlooked when drug companies develop new medications. Type 1 Diabetes “People with T1D and chronic kidney ...
Angie Brown, Quinnipiac University Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren’t limited to competitive athletes. In our everyday lives, ...
If you have CKD, you may need to keep an eye on the phosphorus and potassium levels of the fish you choose. The National Kidney Foundation has a chart you can use to determine levels in specific ...
"Learning and memory are generally associated with brains and brain cells alone, but our study shows that other cells in the body can learn and form memories, too," explains New York University's ...
Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...
Chronic kidney disease can be classified by the extent of your kidney damage. These classifications range from mild, mild to moderate, moderate to severe, severe, and then to most severe kidney ...
The Advisory Committee voted 11 to 3 that the benefits of ZYNQUISTA do not outweigh the risks in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD), as defined in the voting question .
FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel ... a leading late ...